. 2024 Mar 29;15:31–42. doi: 10.2147/SAR.S454436

Table 3.

Pre-Post Treatment Effects for Female and Male Patients (n = 694), Sorted by Effect Size

Mean difference T2 - T1 (female)					Mean difference T2 - T1 (male)
Scale	M	SD	p	ηp²	Scale	M	SD	p	ηp²
ISR_depression^a	−1.08	1.00	***	0.539	ISR_depression^a	−0.77	0.90	***	0.423
Autonomy and joy^b	20.69	21.01	***	0.493	autonomy and joy^b	12.15	18.77	***	0.296
ISR_anxiety^a	−0.64	0.87	***	0.352	ISR_anxiety^a	−0.43	0.83	***	0.212
HEISA_unpleasant feelings^b	16.97	26.68	***	0.289	ERQ_reappraisal	0.51	1.15	***	0.163
ERQ_reappraisal	0.73	1.31	***	0.237	I8_urgency^a	−0.41	0.93	***	0.160
HEISA_temptations and cravings^b	15.20	27.31	***	0.237	perceived self-efficacy^b	1.83	4.24	***	0.157
I8_urgency^a	−0.58	1.05	***	0.233	HEISA_unpleasant feelings^b	6.42	19.20	***	0.152
Perceived self-efficacy^b	2.84	5.28	***	0.226
HEISA_pleasant feelings^b	12.22	23.16	***	0.218
ISR_compulsion^a	−0.43	0.84	***	0.207
ISR_suicidal ideation (n = 57)	0.82	1.31	***	0.287	ISR_suicidal ideation (n = 97)	0.55	1.21	***	0.171
ISR_suicidal ideation (n = 694)	−0.21	0.75	***	0.074	ISR_suicidal ideation (n = 694)	−0.11	0.59	***	0.035

Note. ***p < 0.001; effect size is considered small for ηp2 > 0.01, medium for ηp2 > 0.06 and large for ηp2 > 0.14, only effect sizes ηp² > 0.14 (except for suicidal ideation) are included. n = 67 and n = 97 of the ISR_suicidal ideation variable refers to the improvements of patients, who reported suicidal ideation at T1; M=mean score; SD = standard deviation; a = T1 significantly higher scores for female than male patients at baseline T1; b = significantly higher scores for male than female patients at baseline; between-subject scores for female patients: F(17, 204) = 19.906, p < 0.001, ηp² = 0.624; between-subject scores for male patients: F(17, 456) = 25.248, p < 0.001, ηp² = 0.485 for a detailed overview, see Supplementary Material Table S2.